ACCOUNTS - Final Accounts


Caseware UK (AP4) 2020.0.247 2020.0.247 2021-09-302021-09-30falseNo description of principal activitytrue2020-04-011false1The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 11883001 2020-04-01 2021-09-30 11883001 2019-03-14 2020-03-31 11883001 2021-09-30 11883001 2020-03-31 11883001 c:Director1 2020-04-01 2021-09-30 11883001 d:PlantMachinery 2020-04-01 2021-09-30 11883001 d:PlantMachinery 2021-09-30 11883001 d:PlantMachinery 2020-03-31 11883001 d:PlantMachinery d:OwnedOrFreeholdAssets 2020-04-01 2021-09-30 11883001 d:CurrentFinancialInstruments 2021-09-30 11883001 d:CurrentFinancialInstruments 2020-03-31 11883001 d:CurrentFinancialInstruments d:WithinOneYear 2021-09-30 11883001 d:CurrentFinancialInstruments d:WithinOneYear 2020-03-31 11883001 d:ShareCapital 2021-09-30 11883001 d:ShareCapital 2020-03-31 11883001 d:RetainedEarningsAccumulatedLosses 2021-09-30 11883001 d:RetainedEarningsAccumulatedLosses 2020-03-31 11883001 c:FRS102 2020-04-01 2021-09-30 11883001 c:AuditExempt-NoAccountantsReport 2020-04-01 2021-09-30 11883001 c:FullAccounts 2020-04-01 2021-09-30 11883001 c:PrivateLimitedCompanyLtd 2020-04-01 2021-09-30 iso4217:GBP xbrli:pure

Registered number: 11883001










CLINISCOPE FINANCE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 30 SEPTEMBER 2021

 
CLINISCOPE FINANCE LIMITED
REGISTERED NUMBER: 11883001

BALANCE SHEET
AS AT 30 SEPTEMBER 2021

30 September
31 March
2021
2020
Note
£
£

Fixed assets
  

Tangible assets
 4 
1,683
1,053

  
1,683
1,053

Current assets
  

Debtors: amounts falling due within one year
 5 
115,516
470,073

  
115,516
470,073

Creditors: amounts falling due within one year
 6 
(24,714)
(429,398)

Net current assets
  
 
 
90,802
 
 
40,675

Total assets less current liabilities
  
92,485
41,728

  

Net assets
  
92,485
41,728


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
92,484
41,727

  
92,485
41,728


Page 1

 
CLINISCOPE FINANCE LIMITED
REGISTERED NUMBER: 11883001
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2021

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 31 March 2022.




................................................
Jeremy Elkabir
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
CLINISCOPE FINANCE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 SEPTEMBER 2021

1.


General information

Cliniscope Fiance Limited is a private company limited by share capital, incorporated in England and Wales, registration number 11883001. The address of the registered office is The Priory, Church Lane, Charlbury, Oxfordshire, OX7 3PX.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
CLINISCOPE FINANCE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 SEPTEMBER 2021

2.Accounting policies (continued)


2.4
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
25%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.7

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or income as appropriate. The company does not currently apply hedge accounting for interest rate and foreign exchange derivatives.


3.


Employees

The average monthly number of employees, including directors, during the period was 1 (2020 - 1).

Page 4

 
CLINISCOPE FINANCE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 SEPTEMBER 2021

4.


Tangible fixed assets







Plant and machinery

£



Cost or valuation


At 1 April 2020
1,404


Additions
1,308



At 30 September 2021

2,712



Depreciation


At 1 April 2020
351


Charge for the period on owned assets
678



At 30 September 2021

1,029



Net book value



At 30 September 2021
1,683

Page 5

 
CLINISCOPE FINANCE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 SEPTEMBER 2021

5.


Debtors

30 September
31 March
2021
2020
£
£


Other debtors
115,516
417,292

Prepayments and accrued income
-
52,781

115,516
470,073



6.


Creditors: Amounts falling due within one year

30 September
31 March
2021
2020
£
£

Corporation tax
11,759
9,541

Other creditors
11,823
418,725

Accruals and deferred income
1,132
1,132

24,714
429,398



7.


Related party transactions

At the year end the balance due from the parent company was £115,516 (2020: (£409,368)).

 
Page 6